Research Grants for Preventing Violence (R01)

Research Grants for Preventing Violence (R01) is sponsored by Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC). This initiative supports effectiveness research to evaluate innovative programs, practices, or policies to address the risk for interpersonal violence and suicide among groups experiencing a high burden of these issues.

Expired RFA-CE-08-003: Research for Preventing Violence and Violence –Related Injury (R01) This notice has expired. Check the NIH Guide for active opportunities and notices. Part I Overview Information States Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) at http://www.

cdc. gov/ Participating Organizations National Center for Injury Prevention and Control (NCIPC/CDC) at http://www. cdc.

gov/ncipc/ Title: Research for Preventing Violence and Violence policies, guidelines, terms, and conditions of the HHS Centers for Disease Control and Prevention (CDC) stated in this announcement might differ from those used by the HHS National Institutes of Health (NIH). written guidance for completing this application is not available on the CDC website, then CDC will direct applicants elsewhere for that information.

Authority: This program is authorized under Section 301 (a) [42 U.S.C. 241(a)] of the Public Health Service Act, and Section 391 (a)[42 U.S.C.

280 b(a)] of the Public Health Service Act, as amended Instructions for Submission of Electronic If you do not have access to the Internet, or if you have difficulty accessing the forms online, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: [email protected] .

NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants. gov ( http://www. grants.

gov ) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application must be read in conjunction with the application package instructions included with this announcement on Grants. gov/Apply for Grants (hereafter referred to as, registration process is necessary before submission, and applicants are strongly encouraged to start the process at least four weeks prior to the grant submission date. See Section IV .

steps are required for on time submission: application must be successfully received by Grants. gov no later than 5:00 p. m.

Eastern Standard Time on the application submission receipt date (see Key Dates below.) Applicants must complete a verification step in the Electronic Research Administration (eRA Commons ) within two business days of notification. Note: Since email can be unreliable, it is the responsibility of the applicant to periodically check on their application status in the eRA Commons .

Opportunity Announcement (FOA) Number: RFA-CE-08-003 of Federal Domestic Assistance Number(s): Letter of Intent Receipt Date: January 17, 2008 Application Submission Receipt Date(s): February 15, 2008 Peer Review Date(s): March Council Review Date(s): May Anticipated Start Date(s): September, 2008 Information to Be Available Date: Technical assistance will be available for potential applicants during one conference call.

The call for eligible applicants will be held on January 15, 2008 from 9:30 a. m. to 11:00 a.

m. (Eastern Time). The conference can be accessed by calling: 1-866-704-7564, stating the leader name: Ms Lady Patterson, and entering the passcode: 1314492.

Executive Order 12372 does not apply to this program. NCIPC is soliciting investigator-initiated (R01) research that will expand and advance the understanding of violence, its causes, and prevention strategies. Applications must address one of the research objectives listed in this FOA.

The participating organizations intend to commit a total of $1. 8 million to this RFA for payment of applications responsive to this announcement statement. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Five to six awards will be funded Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the activity code, quality, duration, and costs of the applications received.

Budget Period, Project Period, and Award Amounts: The budget period will be for one year and the anticipated project period up to three years. The funding level will not exceed $300,000 total (including direct and indirect costs) per year.

Eligible Organizations: Public nonprofit organizations; private nonprofit organizations; for profit organizations; small, minority, and women-owned businesses; universities; colleges; research institutions; hospitals; community-based organizations; faith-based organizations; federally recognized or state-recognized American Indian/Alaska Native tribal governments; American Indian/Alaska Native tribally designated organizations; Alaska Native health corporations; urban Indian health organizations; tribal epidemiology centers; state and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and political subdivisions of states (in consultation with states.)

A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, you must provide required documentation from the state or local government as documentation of your status.

Attach this documentation behind the first page of your application form or for electronic applications, use a PDF file and attach as Other Documents and label as appropriate. See Section IV. 1 for application materials.

The SF424 (R&R) Application Guide for this FOA is located at these Web sites: Grants. gov Application Guide SF424 (R&R) - MS Word ; or Grants. gov Application Guide SF424 (R&R) - PDF general information on SF424 (R&R) Application and Electronic Submission, see the following Web sites: SF424 (R&R) Application and Electronic Submission Information ;and General Information on Electronic Submission of Grant Applications .

HHS/CDC Telecommunications for the hearing impaired is available at the following number: TTY 770-488-2783. Funding Opportunity Announcement Glossary: FOA Glossary Terminology Part I Overview Information Part II Full Text of Announcement Section I. Funding Opportunity Description Section II.

Award Information 1. Mechanism(s) of Support 2. Cost Sharing or Matching 3.

Other - Special Eligibility Criteria Section IV. Application and 1. Request Application Information 2.

Content and Form of Application 3. Submission Dates and Times A. Receipt and Review and C.

Application Processing 4. Intergovernmental Review 6. Other Submission Requirements Section V.

Application Review 2. Review and Selection Process 3. Anticipated Announcement and Award Section VI.

Award Administration 2. Administrative and National Policy Rights and Responsibilities Collaborative Responsibilities Section VII. Agency Contact(s) 1.

Scientific/Research Contact(s) 2. Peer Review Contact(s) 3. Financial/ Grants Management 4.

General Questions Contact(s) Section VIII. Other Information - Required Federal Citations II - Full Text of Announcement Section I.

Funding Opportunity Description The National Center for Injury Prevention and Control of CDC within HHS is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010" and to measuring program performance as stipulated by the Government Performance and Review Act (GPRA).

This RFA addresses Healthy People 2010 priority area(s) of injury and violence prevention and is in alignment with NCIPC performance goal(s) to conduct a targeted program of research to reduce injury-related disability. ) For more information , see www. healthypeople.

gov and http://intra-apps. cdc. gov/fmo/ .

The purposes of the NCIPC extramural research program are Build the scientific base for the prevention and control of fatal and nonfatal injuries and related disabilities.

Encourage professionals from a wide spectrum of disciplines of epidemiology, behavioral and social sciences, medicine, biostatistics, public health, health economics, law, criminal justice, and engineering to perform research in order to prevent and control injuries more effectively.

Encourage investigators to propose research that involves intervention development and testing as well as research on methods to enhance the adoption and maintenance of effective intervention strategies among individuals, organizations, or communities. NCIPC is soliciting investigator-initiated research that will help expand and advance our understanding of violence, its causes, and prevention strategies.

The following research objectives are the focus of this 1. Dissemination/Implementation Research Conduct studies aimed at identifying and evaluating efficient and effective methods for the dissemination and implementation of evidence-based interventions, programs, and polices to prevent either the perpetration of or victimization from violence.

This research is intended to bridge the gap between prevention research and everyday practice by building a knowledge base about how evidence-based violence prevention information and strategies are disseminated, translated and integrated for use by communities and policy makers.

Examples of such studies include: examining the optimal ways to synthesize, translate, and package effective prevention approaches; examining ways to build individual and organizational capacities to use effective approaches (i.e., understanding the type and quality of technical assistance training, coaching, monitoring necessary to support effective implementation); understanding how individual, organizational and community characteristics influence the adoption and effective use of empirically-supported violence prevention approaches; and once an effective approach is adopted, understanding the effects of implementing the program, policy, or practice as originally developed (i.e., with fidelity ), as opposed to changing the content or delivery format (i.e., adapting ).

While adaptation occurs with great frequency in the practice field, we know very little about the kinds of modifications that are likely to diminish or increase an intervention’s effectiveness. For this solicitation, funds are available to address dissemination/implementation research in the areas of child maltreatment or youth violence.

Evidence-based interventions, programs, and policies are defined as those for which there is evidence of effectiveness in reducing perpetration of or victimization from child maltreatment or youth violence based on systematic reviews of the field or two or more well designed studies (i.e., experimental, quasi-experimental, time series, or similar designs with appropriate baseline/pre-intervention data, post-intervention data and comparison or control groups).

2. Efficacy/Effectiveness Research efficacy, effectiveness, and cost effectiveness of primary prevention strategies, programs, and policies to prevent the perpetration of violence. These strategies, programs or policies can be targeted universally or at selected or high-risk populations, but cannot be targeted at individuals who have already engaged in the perpetration of violence.

For this solicitation, funds are available to conduct such studies aimed at preventing the perpetration of child maltreatment, intimate partner violence, sexual violence, youth violence, and/or suicidal behavior.

There is particular interest in evaluating approaches that make changes at the family/relationship, community or societal levels of social influence; in evaluating approaches designed to reduce multiple forms of violence; and in approaches aimed at reducing racial/ethnic, gender, and/or economic Conduct studies to examine the development of perpetration.

These studies should be designed to provide a better understanding of the developmental pathways and social circumstances that contribute to the perpetration of violence. Such studies should be designed to provide important information on the populations at high-risk for perpetration, the modifiable risk and protective factors, as well as the optimal developmental periods and settings for intervention.

For this solicitation, funds are available to examine the development of perpetration in the areas of suicidal behavior, intimate partner violence, sexual violence, and/or child maltreatment. See Section VIII, Other Information - Required Federal Citations , for policies related to this announcement. Section II.

Award Information This funding opportunity is a research grant and will use the R01 activity code. This FOA uses just-in-time concepts. It also uses the non-modular budget format described in the SF424 Research and Related (R&R) Budget Component application instructions (see http://grants.

nih. gov/grants/funding budget for the Initial budget Period and the Entire Proposed Period of Support must be submitted with the application. Centers, Institutes, and Offices (CIOs) (NCIPC) intend to commit approximately $1.

8 million (direct and indirect cost) dollars in FY20 08 to fund 5 to 6 applications. The average award amount will be up to $300,000 total (direct and indirect costs) for the first 12-month budget period. An applicant may request a project period of up to 3 years.

An applicant may request up to $300,000 maximum for the first 12-month budget period. The approximate total project period funded amount is $900,000. The anticipated start date for new awards is September, All estimated funding amounts are subject to If an applicant requests a funding amount greater than the ceiling of the award range, HHS/CDC will consider the application non-responsive, and it will not enter into the review process.

HHS/CDC will notify the applicant that the application did not meet the submission Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.

Although the financial plans of the CIO (s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications. III.

Eligibility Information application if your organization has any of the following characteristics: Public nonprofit organizations Private nonprofit organizations Small, minority, and women-owned Community-based organizations Faith-based organizations Federally recognized or state-recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

If you are applying as a bona fide agent of a state or local government, you must provide a letter from the state or local government as documentation of your status. Attach this documentation behind the first page of your application form or for electronic applications, use a . pdf file and attach as Other Documents and label as appropriate.

Cost sharing or matching funds are not current HHS Grants Policy Statement is available at: http://www. hhs. gov/grantsnet/docs/HHSGPS_107.

doc To be considered responsive to this announcement, the applicant institution must provide: Documentation that the institutions principal investigator (s) and project team have prior experience in conducting violence prevention research in the chosen priority area (e.g., dissemination/implementation research, efficacy/effectiveness research, etiologic research in violence).

This must be evidenced by first-authored peer-reviewed publications in the chosen priority area, or experience as the Principal Investigator or Co-Investigator of a current or previous research grant in the chosen priority area. Applicant should clearly identify the relevant publications or grant support.

Documentation of effective and well-defined working relationships with any organization and/or outside entities expected to participate in the proposed research that will ensure implementation of the proposed activities. This should be evidenced by letters of support detailing the nature and extent of the involvement from the performing organization and outside entities (include in the appendices).

The overall match between the proposed theme and research objectives and the program priorities as described under the heading Research Objectives .

In addition: For priority 1, the institution should provide documentation that the proposed research plan for an evidence-based intervention, program, or policy chosen for this priority (dissemination/implementation research in either the area of child maltreatment or youth violence) has been previously evaluated and demonstrated effective for the outcome of interest.

Include in the appendices, published results from at least two or more well-designed studies showing evidence of effectiveness, or a systematic review of the field (e.g., Cochrane Review, Blueprints for Violence Prevention Task Force on Community Preventive Services) that identifies the intervention, program, or policy as effective.

For priority 2 (efficacy/effectiveness research), only proposals that evaluate a strategy, program, or policy that is focused on primary, not secondary prevention of perpetration of violence, and focuses on a target population that has not already engaged in the perpetration of violence will be considered responsive to the objectives of the FOA.

For priority 3 (etiologic research), only applications that propose to examine the development of perpetration in the areas of interest for this solicitation will be considered responsive. applicant institution can submit more than one application in response to this FOA, but may not submit more than one application with the same principal investigator. Accepted applications will remain active for one year from the receipt date.

Applicants may not submit a revised or amended application for subsequent receipt dates, but may submit a previously reviewed, unfunded submission as a new application that will compete with other submitted application is incomplete or non-responsive to the special requirements listed in this section, it will not be entered into the review process.

the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting an award, Section IV. Application and Submission Information (R&R) Application Package and SF424 (R&R) Application Instructions for completing the SF424 (R&R) forms for this FOA, link to Grants.

gov/Apply and follow the directions provided on that Web site. A one-time registration is required for institutions/organizations at the following: Grants. gov Get Registered, http://www.

grants. gov/applicants/get_registered. jsp eRA Commons Prepare to Apply, http://era.

nih. gov/ElectronicReceipt/preparing. htm applicant organization, as well as the PD/PI must register in eRA Commons for an application to be accepted electronically.

The Credentials Log-In, referenced in Section IV. 2 . Content and Form of Application Submission, is obtained through Step #3 in the required actions below.

their institutions/organizations to make sure they are registered in the eRA The following three steps are required before an applicant institution/organization can submit an electronic application, as follows: Organizational/Institutional Registration in Grants. gov Get Registered, http://www. grants.

gov/applicants/get_registered. jsp Your organization will need to Universal Number System (DUNS) number and register with the Central Contractor Registration (CCR) as part of the Grants. gov registration process.

If your organization does not have a Taxpayer Identification Number (TIN) or Employer Identification Number (EIN), allow for extra time. A valid TIN or EIN is necessary for CCR registration. The CCR also validates the EIN against Internal Revenue Service records, a step that will take an additional one to two business days.

If Foreign Institutions are listed in Section III. 1. A.

Eligible Institutions, include the following bullet: Applicants outside the US are required to include a NATO Commercial and Government Entity (NCAGE) number on their CCR registration. See section IV. 2.

Content and Form of Application Submission, for instructions. Direct questions regarding Grants. gov registration to: Grants.

gov Customer Support Business Hours: M-F 7:00 a. m. - 9:00 p.

m. Eastern Time Organizational/Institutional Registration in the eRA Commons Prepare to Apply, http://era. nih.

gov/ElectronicReceipt/preparing. htm To find out if an organization is already eRA Commons-registered, see the " List of Grantee Organizations Registered in eRA Commons. Direct questions regarding the eRA Phone: 301-402-7469 or 866-504-9552 (Toll Free) Business hours M-F 7:00 a.

m. 8:00 p. m.

Eastern Time Director/Principal Investigator (PD/PI) Registration in the eRA Commons: Refer to the NIH eRA Commons System (COM) The individual designated as the PD/PI on the application must also be registered in the eRA Commons. It is not necessary for PDs/PIs to register with Grants. gov. The PD/PI must hold a PD/PI account in the eRA Commons and must be affiliated with the applicant organization.

This account cannot have any other role attached to it other than the PD/PI. This registration/affiliation must be done by the Authorized Organization Representative/Signing Official (AOR/SO) or their designee who is already registered in the eRA Commons.

Both the PD/PI and AOR/SO need separate accounts in the eRA Commons since both hold different roles for authorization and to view also an HHS peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization.

Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government. Several of the steps of the registration process could take four weeks or more. Therefore, applicants should immediately check with their business official to determine whether their organization/institution is already registered in both Grants.

gov and the eRA Commons . The HHS/CDC strongly encourages applicants to use the Grants. gov electronic applications process and have organizations and PD/PIs complete all necessary registrations.

Request Application Information Applicants must download the SF424 (R&R) application forms and SF424 (R&R) Application Guide for this FOA through Grants. gov/Apply . Only the forms package directly attached to a specific FOA can be used.

You will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA) although some of the "Attachment" files may be useable for more than one FOA. If you do not have access to the Internet, or if you have difficulty accessing the forms online, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff.

For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: [email protected] . HHS/CDC Telecommunications for the hearing impaired: TTY 770-488-2783. of Application Submission applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide ( MS Application Guide is critical to submitting a complete and accurate application to HHS/CDC.

There are fields within the SF424 (R&R) application components that, although not marked as mandatory, are required by HHS/CDC ( e.g., the Credential log-in field of the Research & Related Senior/Key Person Profile component must contain the PD/PI assigned eRA Commons User ID ). Agency-specific instructions for such fields are clearly identified in the Application Guide.

For additional information, see Tips and Tools for Navigating Electronic Submission on the front page of Electronic Submission of Grant application is comprised of data arranged in separate components. Some components are required, others are optional. The forms package associated with this FOA in Grants.

gov/APPLY will include all applicable components, mandatory and optional.

A completed application in response to this FOA will include the following components: Research & Related Project/Performance Site Research & Related Other Project Information Research & Related Senior/Key Person Research & Related Budget Research & Related Subaward Budget Attachment(s) both budget components are included in the SF424 (R&R) forms package, the CDC R01 (activity code) uses ONLY the detailed Research & Related Budget.

(Do not use the PHS Submission Dates and Times See Section IV. 3. A for details Submission, Review and Anticipated Start Dates Receipt Date: January 17, 2008 Submission Receipt Date(s): February 15, 2008 Review Date: March - April, 2008 Anticipated Start Date: September, 2008 Prospective applicants are asked to submit a letter of intent that includes the following information: title of proposed research.

and telephone number of the Principal Investigator. of this funding opportunity letter of intent is not required , is not binding, and does not enter into the review of a subsequent application, the information that it contains allows CDC Program staff to estimate the potential review workload and plan the review.

The letter of intent is to be sent by the date listed The letter of intent should be sent by mail, fax or NCIPC Extramural Resources Team CDC, National Center for Injury Prevention and Control Address for Express Mail or Delivery Service: Yale Building , Room 2054 Address for U.S. Postal Service Mail: 4770 Buford Hwy. NE, Mailstop K-62 Telephone: (770) 488-4037 3. B.

Submitting an Application to CDC If the instructions in this announcement differ in any way from the SF424 R&R instructions, follow the instructions in this To submit an application in response to this FOA, applicants should access this FOA via http://www. grants. gov/Apply and follow steps 1-4.

If submittal of the application is done electronically through Grants. gov ( http://www. grants.

gov ), the application will be electronically time/date stamped by Grants. gov. The applicants Authorized Organization Representative (AOR) will receive an e-mail notice of receipt from eRA Commons and Grants. gov when HHS/CDC receives the All requested information must be received in the HHS/CDC Procurement and Grants Office by 5:00 p.

m. Eastern Standard Time on the deadline date. If an applicant submits materials by the United States Postal Service or commercial delivery service, you must ensure that the carrier will be able to guarantee delivery by the closing date and time.

If HHS/CDC receives your submission after closing because of : (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time, or (2) significant weather delays or natural disasters, you have the opportunity to submit documentation of the carrier’s guarantee.

If the documentation verifies a carrier problem, HHS/CDC will consider the submission as having been received by the deadline. announcement is the definitive guide on Letter Of Intent (LOI) and application content, submission address, and deadline. It supersedes information provided in the application instructions.

If your application does not meet the deadline described in Section IV. 3. A , it will not be eligible for review, and HHS/CDC will discard it.

You will receive notification that you did not meet the submission requirements. Otherwise, HHS/CDC will not notify you upon receipt of your paper submission. If you have a question about the receipt of your application, first contact your courier.

If you still have a question, contact the PGO-TIMS staff at: 770-488-2700. Before calling, please wait two to three days after the submission deadline. This will allow time for HHS/CDC to process and log submissions.

If submitting a paper application, it must be prepared using the 424 R&R instructions for preparing a research grant application. Submit a signed, typewritten original of the application and all appendices, including the checklist, and three signed photocopy(s) to the following address: Technical Information Management Section RFA-CE-08 -003 CDC, Procurements and Grants Office U.S. Department of Health and Human Services 3. C.

Application Processing HHS/CDC must receive applications on or before 5:00 P. M. Eastern Standard Time on the application submission date(s) described above ( Section IV.

3. A. ).

If HHS/CDC receives an application after that submission date and time, the application may be delayed in the review process or not reviewed. package has been successfully submitted through Grants. gov, any errors have been addressed, and the assembled application has been created in the eRA Commons, the PD/PI and the Authorized Organization Representative/Signing Official (AOR/SO) have two business days to view the application image.

everything is acceptable, no further action is necessary. The application will automatically move forward for processing by the CDC, PGO, Technical Information Management Section, after two business days. to the submission deadline, the AOR/SO can Reject the assembled application and submit a changed/corrected application within the two day viewing window.

This option should be used if the AOR/SO determines that warnings should be addressed. Reminder: warnings do not stop further application processing. If an application submission results in warnings (but no errors) it will automatically move forward after two business days if no action is taken.

Please remember that some warnings may not be applicable or may need to be addressed after application submission. the two day window falls after the submission deadline, the AOR/SO will have the option to Reject the application if, due to an eRA Commons or Grants.

gov system issue, the application does not correctly reflect the submitted application package (e.g., some part of the application was lost or didn t transfer correctly during the submission process). The AOR/SO should first contact the eRA Commons Helpdesk to confirm the system error, document the issue, and determine the best course of action. HHS/CDC will not penalize the applicant for an eRA Commons or Grants.

gov system issue. the AOR/SO chooses to Reject the image after the submission deadline for a reason other than an eRA Commons or Grants. gov system failure, a changed/corrected application still can be submitted but it will be subject to the CDC late policy guidelines and may not be accepted.

The reason for this delay should be explained in the cover letter attachment and must refer only to Commons errors and/or technical errors. the AOR/SO and PD/PI will receive e-mail notifications when the application is rejected or the application automatically moves forward in the process after receipt, applications will be evaluated for completeness and responsiveness by NCIPC and HHS/CDC Procurement and Grants Office (PGO).

HHS/CDC will not review incomplete and non-responsive applications. will be an acknowledgement of receipt of applications from Grants. gov and the eRA Commons .

The HHS/ CDC will not accept any application in response to this FOA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. However, when a previously unfunded application, originally submitted as an investigator-initiated application, is to be submitted in response to a funding opportunity, it is to be prepared as a NEW application.

That is, the application for the funding opportunity must not include an Introduction describing the changes and improvements made, and the text must not be marked to indicate the changes from the previous unfunded version of the 4. Intergovernmental Review Executive Order 12372 does not apply to this program.

awards are subject to the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement. Restrictions, which applicants must take into account while writing their budgets, are as follows: Funds relating to the conduct of human subject research will be restricted until the appropriate assurances and Institutional Review Board approvals are in place.

Reimbursement of pre-award costs is not allowed. Grant funds will not be made available to support the provision of direct care. Eligible applicants may enter into contracts, including consortia agreements, as necessary to meet the requirements of the program and strengthen the overall application.

Travel expenses for the annual monitoring workshop in Atlanta should be included in the applicant’s proposed budget.) A detailed categorical budget for the Initial budget Period and the Entire Proposed Period of Support must be submitted with the application. If you are requesting indirect costs in your budget, you must include a copy of your indirect cost rate agreement.

If your indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. If submitting electronically, use a PDF version of the agreement, attach it in Grants. gov under Other Attachments , and title it appropriately.

Applicants research plan(s) should address activities they will conduct over the entire project period. HHS/CDC requires the PD/PI to fill in his/her eRA Commons User ID in the PROFILE Project Director/Principal Investigator section, Credential log-in field of the Research & Related Senior/Key Person Profile component. The applicant organization must include its DUNS number in its Organizational Profile in the